Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

计划入组 126 人 · 首次发布于 2024 年 9 月 3 日

High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)

计划入组 32 人 · 首次发布于 2026 年 7 月 13 日

Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)

计划入组 39 人 · 首次发布于 2024 年 10 月 30 日

GLP-1 agonist (Humedix/HLB Pharma)

Recombinant glucagon-like peptide-1 receptor agonist

glucagon-like peptide 1 receptor agonist (oral, diabetes/obesity)

Alturas Minerals Corp

United States

Arvinas Estrogen Receptor, Inc.

United States

NHI-1

United States

Verdiva Bio Launches with $410M to Advance Oral GLP-1RA for Obesity

Gan & Lee's Oral GLP-1 Agonist GZR18 Shows Promise in Phase 1 Trial

Novo Nordisk's CagriSema Shows Promise in Weight Loss and Diabetes Treatment